NRX Pharmaceuticals Inc (NASDAQ:NRXP) has a beta value of 1.25 and has seen 1.28 million shares traded in the last trading session. The company, currently valued at $19.83M, closed the last trade at $1.64 per share which meant it gained $0.44 on the day or 36.67% during that session. The NRXP stock price is -346.95% off its 52-week high price of $7.33 and 32.93% above the 52-week low of $1.10. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.17 million shares traded. The 3-month trading volume is 143.50K shares.
The consensus among analysts is that NRX Pharmaceuticals Inc (NRXP) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.29.
NRX Pharmaceuticals Inc (NASDAQ:NRXP) trade information
Sporting 36.67% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the NRXP stock price touched $1.64 or saw a rise of 2.38%. Year-to-date, NRX Pharmaceuticals Inc shares have moved -64.35%, while the 5-day performance has seen it change 35.54%. Over the past 30 days, the shares of NRX Pharmaceuticals Inc (NASDAQ:NRXP) have changed 37.82%. Short interest in the company has seen 0.68 million shares shorted with days to cover at 4.8.
Wall Street analysts have a consensus price target for the stock at $2, which means that the shares’ value could jump 18.0% from current levels. The projected low price target is $2.0 while the price target rests at a high of $2.0. In that case, then, we find that the current price level is -21.95% off the targeted high while a plunge would see the stock gain -21.95% from current levels.
NRX Pharmaceuticals Inc (NRXP) estimates and forecasts
Figures show that NRX Pharmaceuticals Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -46.23% over the past 6 months, with this year growth rate of 52.70%, compared to 16.50% for the industry. Revenue growth from the last financial year stood is estimated to be 0.00%.
1 have an estimated revenue figure of 5M for the next ending quarter.
NRXP Dividends
NRX Pharmaceuticals Inc is expected to release its next earnings report in January this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
NRX Pharmaceuticals Inc (NASDAQ:NRXP)’s Major holders
Insiders own 23.56% of the company shares, while shares held by institutions stand at 6.05% with a share float percentage of 7.92%. Investors are also buoyed by the number of investors in a company, with NRX Pharmaceuticals Inc having a total of 21.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are AdvisorShares Trust-AdvisorShares Psychedelics ETF and Vanguard Total Stock Market Index Fund . As of Oct 31, 2024 , the former fund manager holds about 2.41% shares in the company for having 291.27 shares of worth $0.48 million while later fund manager owns 193.42 shares of worth $0.32 million as of Sep 30, 2024 , which makes it owner of about 1.60% of company’s outstanding stock.
